Nautilus Biotechnology, Inc.NAUTNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank71
3Y CAGR-11.7%
5Y CAGR-25.6%
Year-over-Year Change
Year-over-year earnings per share growth rate
3Y CAGR
-11.7%/yr
Annual compound
5Y CAGR
-25.6%/yr
Recent acceleration
Percentile
P71
Within normal range
vs 5Y Ago
0.2x
Contraction
Streak
2 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 16.07% |
| 2024 | -9.80% |
| 2023 | -10.87% |
| 2022 | 23.33% |
| 2021 | -27.66% |
| 2020 | 70.44% |
| 2019 | -101.82% |
| 2018 | 0.00% |